PERDOVE ANZIANI: a Prospective Cohort Study on Older Patients
NCT ID: NCT01699984
Last Updated: 2012-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
329 participants
OBSERVATIONAL
2011-02-28
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients are followed from the first day of hospitalization until discharge or up to 3 months and 1 day after the date of admission ("long-term care" patients).
At admission a "Patient Form" including social, demographic and clinical informations and a series of standardized assessment tools is completed with the help of clinicians, nurses and caregivers (when available).
For each patient, during hospitalization, an analysis of apolipoprotein ApoE polymorphisms is performed and adverse events occurred during hospitalization are monitored, as well as the predictive abilities of clinicians and any recent CT and MRI. Patients are reassessed at discharge (or after 3 months for "long-term care" patients) and at 6 months follow-up of with a standardized telephone interview to assess clinical and functional status and possible changes in the residential status of the patient.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized patients
All patients hospitalized in 4 inpatient facilities in Northern Italy during 4 index-months.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent provided
Exclusion Criteria
* informed consent not provided
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Centro San Giovanni di Dio Fatebenefratelli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giovanni de Girolamo, M.D.
M.D., Scientific Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni de Girolamo, M.D.
Role: PRINCIPAL_INVESTIGATOR
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brescia, Brescia, Italy
Sacro Cuore di Gesù Centre
San Colombano al Lambro, Milan, Italy
beata Vergine della Consolata Hospital
San Maurizio Canavese, Turin, Italy
San Raffaele Arcangelo Hospital
Venezia, Venezia, Italy
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website of the coordinating centre
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-1-PEV
Identifier Type: -
Identifier Source: org_study_id